APA

Harbour D. A., Gunn-Moore D. A., Gruffydd-Jones T. J., Caney S. M. A., Bradshaw J., Jarrett O. & Wiseman A. (20030219). Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine. : Vaccine.

Chicago

Harbour D A, Gunn-Moore D A, Gruffydd-Jones T J, Caney S M A, Bradshaw J, Jarrett O and Wiseman A. 20030219. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine. : Vaccine.

Harvard

Harbour D. A., Gunn-Moore D. A., Gruffydd-Jones T. J., Caney S. M. A., Bradshaw J., Jarrett O. and Wiseman A. (20030219). Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine. : Vaccine.

MLA

Harbour D A, Gunn-Moore D A, Gruffydd-Jones T J, Caney S M A, Bradshaw J, Jarrett O and Wiseman A. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine. : Vaccine. 20030219.